These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Can somatostatin prevent injection pancreatitis after ERCP? Persson B; Slezak P; Efendic S; Häggmark A Hepatogastroenterology; 1992 Jun; 39(3):259-61. PubMed ID: 1380475 [TBL] [Abstract][Full Text] [Related]
23. Impact of intraduodenal acetic acid infusion on pancreatic duct cannulation during endoscopic retrograde cholangiopancreatography: A double-blind, randomized controlled trial. Fang J; Wang SL; Zhao SB; Hu LH; Yao J; Shen Z; Gu L; Xia T; Cai Q; Li ZS; Bai Y J Gastroenterol Hepatol; 2018 Oct; 33(10):1804-1810. PubMed ID: 29633339 [TBL] [Abstract][Full Text] [Related]
24. Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography. Lieb JG; Draganov PV World J Gastroenterol; 2007 Jul; 13(26):3567-74. PubMed ID: 17659706 [TBL] [Abstract][Full Text] [Related]
25. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Poon RT; Yeung C; Lo CM; Yuen WK; Liu CL; Fan ST Gastrointest Endosc; 1999 May; 49(5):593-8. PubMed ID: 10228257 [TBL] [Abstract][Full Text] [Related]
26. Clinical usefulness of double-guidewire technique for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography. Ito K; Horaguchi J; Fujita N; Noda Y; Kobayashi G; Koshita S; Kanno Y; Ogawa T; Masu K; Hashimoto S Dig Endosc; 2014 May; 26(3):442-9. PubMed ID: 23937334 [TBL] [Abstract][Full Text] [Related]
27. Idiopathic recurrent pancreatitis: long-term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment. Testoni PA; Caporuscio S; Bagnolo F; Lella F Am J Gastroenterol; 2000 Jul; 95(7):1702-7. PubMed ID: 10925971 [TBL] [Abstract][Full Text] [Related]
28. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Aizawa T; Ueno N Gastrointest Endosc; 2001 Aug; 54(2):209-13. PubMed ID: 11474392 [TBL] [Abstract][Full Text] [Related]
29. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014. Dumonceau JM; Andriulli A; Elmunzer BJ; Mariani A; Meister T; Deviere J; Marek T; Baron TH; Hassan C; Testoni PA; Kapral C; Endoscopy; 2014 Sep; 46(9):799-815. PubMed ID: 25148137 [TBL] [Abstract][Full Text] [Related]
30. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155 [TBL] [Abstract][Full Text] [Related]
32. [Double sphincterostomy of pancreatic and choledochal sphincters in the treatment of chronic recurrent pancreatitis]. Guelrud M; Mendoza S; Plaz J; Mujica V G E N; 1991; 45(1):23-5. PubMed ID: 1688212 [TBL] [Abstract][Full Text] [Related]
33. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Sherman S; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Earle D; Temkit M; Lehman GA Gastrointest Endosc; 2003 Jul; 58(1):23-9. PubMed ID: 12838216 [TBL] [Abstract][Full Text] [Related]
35. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104 [TBL] [Abstract][Full Text] [Related]
36. Risk factors of post- endoscopic retrograde cholangiopancreatography pancreatitis in biliary type sphincter of Oddi dysfunction in Japanese patients. Miyatani H; Matsumoto S; Mashima H J Dig Dis; 2017 Oct; 18(10):591-597. PubMed ID: 28898571 [TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin injection after biliary sphincterotomy. Gorelick A; Barnett J; Chey W; Anderson M; Elta G Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315 [TBL] [Abstract][Full Text] [Related]
38. Post-ERCP pancreatitis. Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323 [TBL] [Abstract][Full Text] [Related]
39. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547 [TBL] [Abstract][Full Text] [Related]
40. Effect of native somatostatin on Sphincter of Oddi motility in patients with acute recurrent pancreatitis. A pilot study with Ultrasound-Secretin test. Di Francesco V; Angelini G; Zoico E; Zamboni M; Frulloni L; Cavallini G Dig Liver Dis; 2006 Apr; 38(4):268-71. PubMed ID: 16540384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]